X-71366210-A-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000715246.1(TAF1):​c.-105A>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.28 ( 656 hom., 1239 hem., cov: 0)
Exomes 𝑓: 0.072 ( 233 hom. 861 hem. )

Consequence

TAF1
ENST00000715246.1 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -7.38

Publications

2 publications found
Variant links:
Genes affected
TAF1 (HGNC:11535): (TATA-box binding protein associated factor 1) Initiation of transcription by RNA polymerase II requires the activities of more than 70 polypeptides. The protein that coordinates these activities is the basal transcription factor TFIID, which binds to the core promoter to position the polymerase properly, serves as the scaffold for assembly of the remainder of the transcription complex, and acts as a channel for regulatory signals. TFIID is composed of the TATA-binding protein (TBP) and a group of evolutionarily conserved proteins known as TBP-associated factors or TAFs. TAFs may participate in basal transcription, serve as coactivators, function in promoter recognition or modify general transcription factors (GTFs) to facilitate complex assembly and transcription initiation. This gene encodes the largest subunit of TFIID. This subunit binds to core promoter sequences encompassing the transcription start site. It also binds to activators and other transcriptional regulators, and these interactions affect the rate of transcription initiation. This subunit contains two independent protein kinase domains at the N- and C-terminals, but also possesses acetyltransferase activity and can act as a ubiquitin-activating/conjugating enzyme. Mutations in this gene result in Dystonia 3, torsion, X-linked, a dystonia-parkinsonism disorder. Alternative splicing of this gene results in multiple transcript variants. This gene is part of a complex transcription unit (TAF1/DYT3), wherein some transcript variants share exons with TAF1 as well as additional downstream DYT3 exons. [provided by RefSeq, Oct 2013]
TAF1 Gene-Disease associations (from GenCC):
  • intellectual disability, X-linked, syndromic 33
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Illumina
  • X-linked dystonia-parkinsonism
    Inheritance: XL, Unknown Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)
  • X-linked intellectual disability-global development delay-facial dysmorphism-sacral caudal remnant syndrome
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant X-71366210-A-C is Benign according to our data. Variant chrX-71366210-A-C is described in ClinVar as [Benign]. Clinvar id is 1227807.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.489 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TAF1NM_004606.5 linkc.-165A>C upstream_gene_variant ENST00000423759.6 NP_004597.3 P21675

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TAF1ENST00000423759.6 linkc.-165A>C upstream_gene_variant 5 NM_004606.5 ENSP00000406549.2 P21675

Frequencies

GnomAD3 genomes
AF:
0.283
AC:
7377
AN:
26062
Hom.:
656
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.499
Gnomad AMI
AF:
0.0204
Gnomad AMR
AF:
0.158
Gnomad ASJ
AF:
0.0313
Gnomad EAS
AF:
0.00778
Gnomad SAS
AF:
0.0639
Gnomad FIN
AF:
0.0316
Gnomad MID
AF:
0.0467
Gnomad NFE
AF:
0.0535
Gnomad OTH
AF:
0.207
GnomAD4 exome
AF:
0.0719
AC:
8309
AN:
115583
Hom.:
233
Cov.:
3
AF XY:
0.0360
AC XY:
861
AN XY:
23909
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.367
AC:
2104
AN:
5735
American (AMR)
AF:
0.0791
AC:
362
AN:
4579
Ashkenazi Jewish (ASJ)
AF:
0.0331
AC:
102
AN:
3084
East Asian (EAS)
AF:
0.00805
AC:
51
AN:
6336
South Asian (SAS)
AF:
0.100
AC:
829
AN:
8260
European-Finnish (FIN)
AF:
0.0556
AC:
655
AN:
11783
Middle Eastern (MID)
AF:
0.106
AC:
40
AN:
376
European-Non Finnish (NFE)
AF:
0.0525
AC:
3660
AN:
69683
Other (OTH)
AF:
0.0880
AC:
506
AN:
5747
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.362
Heterozygous variant carriers
0
394
788
1183
1577
1971
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
70
140
210
280
350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.283
AC:
7397
AN:
26097
Hom.:
656
Cov.:
0
AF XY:
0.225
AC XY:
1239
AN XY:
5497
show subpopulations
African (AFR)
AF:
0.499
AC:
6493
AN:
13009
American (AMR)
AF:
0.157
AC:
297
AN:
1890
Ashkenazi Jewish (ASJ)
AF:
0.0313
AC:
12
AN:
384
East Asian (EAS)
AF:
0.00778
AC:
5
AN:
643
South Asian (SAS)
AF:
0.0615
AC:
24
AN:
390
European-Finnish (FIN)
AF:
0.0316
AC:
25
AN:
791
Middle Eastern (MID)
AF:
0.0526
AC:
5
AN:
95
European-Non Finnish (NFE)
AF:
0.0535
AC:
448
AN:
8372
Other (OTH)
AF:
0.202
AC:
86
AN:
425
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
214
428
642
856
1070
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
80
160
240
320
400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0703
Hom.:
267

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 22, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.76
CADD
Benign
0.67
DANN
Benign
0.19
PhyloP100
-7.4
PromoterAI
-0.078
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7055342; hg19: chrX-70586060; API